Physician

Francis Charles Jansen, M.D.

According to 2025 Medicare claims, Francis Jansen, M.D. (NPI: 1770578239) practices ophthalmology in the Springfield, MO market, with the plurality of this provider's patient population coming from Greene, MO. This provider's primary affiliated billing organization is MISSOURI EYE INSTITUTE LLC (NPI: 1144277252; TIN: 770661128) and primary practice location at 65804-6539. Jansen is affiliated with the Mercy Health ACO, LLC (ACO ID: A2616), participating under the MSSP model.

Jansen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 653 traditional Medicare patients, billed 2,646 HCPCS/CPT codes, and received $207,563 in Medicare payments. The top billing code was 66984 (Removal of cataract with insertion of prosthetic lens). Part D data shows 2,604 prescription claims across 700 beneficiaries totaling $355,849 in drug costs, led by Xiidra (Lifitegrast). 2019 DME data shows 11 claims. Open Payments data shows 14 records totaling $613. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $528,046 to $207,563. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,375	4,828	$528,046
2016	1,328	4,959	$471,483
2017	1,378	5,301	$476,191
2018	1,308	5,331	$453,446
2019	1,112	4,834	$400,784
2020	870	3,479	$284,890
2021	891	3,593	$308,240
2022	843	3,389	$289,002
2023	743	3,230	$263,588
2024	653	2,646	$207,563

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,081	3,959	$304,728
2016	1,057	3,765	$291,318
2017	1,110	3,877	$308,772
2018	1,101	3,961	$331,568
2019	859	3,083	$303,893
2020	677	2,814	$283,558
2021	738	3,057	$302,791
2022	672	2,623	$295,270
2023	693	2,474	$297,049
2024	700	2,604	$355,849

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	11	$403
2016	11	11	$514
2017	12	12	$494
2018	N/R	N/R	N/R
2019	11	11	$539
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
66984	Removal of cataract with insertion of prosthetic lens	127	210	$351
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	154	154	$98
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	166	182	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	244	328	$58
92136	Measurement of corneal curvature and depth of eye	119	203	$26

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xiidra	Lifitegrast	104	4,620	$106,276
Restasis	Cyclosporine	112	5,010	$104,818
Lumigan	Bimatoprost	65	3,609	$38,082
Combigan	Brimonidine Tartrate/Timolol	63	2,828	$20,604
Alphagan P	Brimonidine Tartrate	70	2,399	$15,720

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$613	Sight Sciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Francis Charles Jansen, M.D.?

Tedicare shows public-source Medicare data for Francis Charles Jansen, M.D. (NPI 1770578239), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Francis Charles Jansen, M.D. have ACO affiliation data?

Francis Charles Jansen, M.D. is shown with ACO affiliation data for Mercy Health ACO, LLC (MSSP, ACO ID A2616).

What billing organization is linked to Francis Charles Jansen, M.D.?

Francis Charles Jansen, M.D. is linked to MISSOURI EYE INSTITUTE LLC (billing NPI 1144277252) in the available physician profile data.

Does Francis Charles Jansen, M.D. have Open Payments data?

Francis Charles Jansen, M.D. has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.